TruSight Lymphoma 40
Expert-defined panel targeting somatic mutations associated with lymphomas.
Read More...
TruSight Lymphoma 40 uses expert-defined content and proven next-generation sequencing (NGS) technology to identify somatic variants associated with lymphomas.
The panel content was designed by a consortium of recognized lymphoma experts with input from industry guidelines1,2 and relevant literature.3 The panel targets genes frequently mutated in lymphomas, including:
TruSight Lymphoma 40 covers 9 fullgenes (exons only) and exonic hotspots on 31 additional genes, providing a comprehensive assessment of key genes known to be associated with lymphomas in a single test. The result is an accurate, cost-effective solution that enables researchers to profile this class of hematological malignancies.
TruSight Lymphoma 40 libraries are ideally suited to run on the MiSeq System. Sequence data generated from TruSight Lymphoma 40 libraries are analyzed using on-instrument MiSeqReporter software or the Amplicon DS BaseSpace App. Filtering and annotation can then be performed using BaseSpace Variant Interpreter or Variant StudioSoftware.
Literature is not currently available for this product.
A dedicated support section is not currently available for this product
This sequencing research panel targets variants associated with myeloid malignancies such as AML, MDS, MPN, CML, CMML, and JMML.
Provides comprehensive gene fusion detection in formalin-fixed, paraffin-embedded (FFPE) and other cancer research samples.
Targeting 1385 cancer genes for gene expression, variant, and fusion detection studies in many RNA sample types including blood, bone marrow, and formalin-fixed, paraffin-embedded (FFPE) tissue.
Focused sequencing panel to assess 15 genes that are commonly mutated in solid tumors in a single assay, with a simple, rapid workflow.
